A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)
Clinical trial NCT02616185 · TERMINATED
Trial details
- NCT number
- NCT02616185
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-30
- Primary completion
- 2021-02-23
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.